Alexey Amunts (Stockholm University/SciLifeLab) is one of four early career investigators selected to receive a six-year research support from the Swedish Cancer Society, Cancerfonden. His research group studies how proteins are synthesized, folded and assembled into functional multicomponent membrane complexes that drive the cellular energy production, processes reportedly upregulated in cancer. Alexey Amunts is also a user of and contributor to the Cryo-EM technology available at SciLifeLab.
The Swedish Cancer Society has allocated 614 million SEK to medical research in 2018, and over 10 billion SEK since its establishment.
More information about the granted researchers